Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Cervical cord and ventricle affection in neuromyelitis optica.
Regulation of B cell function by the immunosuppressive agent leflunomide.
Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Effect of smoking on multiple sclerosis: a meta-analysis.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Interferon-beta1b for the treatment of multiple sclerosis.
Management of women with multiple sclerosis through pregnancy and after childbirth.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
The cell biology of CNS myelination.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.

Pages